Skip to main content
Clinical Trials/CTRI/2023/07/054981
CTRI/2023/07/054981Not yet recruitingPhase 2

Evaluation of antihypertensive effect of herbomineral drug- A randomised controlled comparative open clinical trial

Parul Ayurved Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Diagnosed hypertension patients.
  • 2. K/c/o hypertension with or without antihypertensive drugs. (With or without symptoms).
  • 3. Patients with: Stage 1 hypertension SBP (140-159)/DBP (90-99) mm of Hg

Exclusion Criteria

  • 1. Acute haemorrhagic condition, Acute septic shock
  • 2. K/c/o hypertension history more than 12 years.
  • 3. Hypertensive emergency i.e. blood pressure more than 180/120mm of Hg.
  • 4. Secondary hypertension.
  • 5. Pregnancy-induced hypertension.
  • 6. Pregnant and lactating women.

Investigators

Sponsor
Parul Ayurved Hospital

Similar Trials